The exact reasons are not fully understood, but potential factors include genetic differences, interactions with other medications, and underlying health conditions that may reduce the effectiveness of GLP-1 drugs for weight loss in certain people
Key Interactions and Monitoring Parameters for Combined Therapy The primary concern when combining testosterone and semaglutide is enhanced cardiovascular stress
Other Considerations Pancreatitis represents a rare but serious potential concern with all incretin-based medications
Neither Sprintec nor Junel Fe is recommended for women who have a history of blood clots, certain cancers, uncontrolled high blood pressure, or who are pregnant
At week 56, patients in the liraglutide group had lost a mean of 8.4 7.3 kg of body weight, whereas those in the placebo group had lost a mean of 2.8 6.5 kg (mean difference of 5.6 kg) [22]